# Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by Rubus ulmifolius Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes Mellitus

**Authors:** Sonia Floris, Barbara Noli, Cristina Cocco, Antonella Fais, Benedetta Era, Carlo Ignazio Giovanni Tuberoso, Valentina Masala, Franca Piras, Valeria Sogos, Amalia Di Petrillo, Antonio De Agostini, Francesca Pintus, Cinzia Sanna

PMC · DOI: 10.3390/plants14213247 · Plants · 2025-10-23

## TL;DR

This study shows that Rubus ulmifolius fruit extract can help manage type 2 diabetes by inhibiting key enzymes and preventing harmful protein buildup.

## Contribution

The study demonstrates the extract's strong α-glucosidase inhibition and IAPP fibril prevention, offering a new natural therapeutic approach for T2D.

## Key findings

- The extract inhibited α-glucosidase 32 times more effectively than acarbose with an IC50 of 2.8 µg/mL.
- It significantly reduced islet amyloid polypeptide aggregation in a dose-dependent manner.
- The extract showed antioxidant and anti-inflammatory effects without cytotoxicity in Caco-2 cells.

## Abstract

This study examines the antidiabetic potential of Rubus ulmifolius, a shrub traditionally used for medicinal and nutritional purposes. The aim was to assess the fruit extract’s inhibitory effect on α-amylase and α-glucosidase, therapeutic targets in type 2 diabetes (T2D), given their role in carbohydrate digestion. Considering the role of islet amyloid polypeptide (IAPP) aggregation in pancreatic β-cell dysfunction in T2D, the extract’s effect on inhibiting this process was also evaluated. Cytocompatibility and antioxidant effects were tested in Caco-2 cells, while caspase-1 activity was measured to evaluate anti-inflammatory potential. Phytochemical analysis of R. ulmifolius fruits revealed various phenolic compounds, with anthocyanin as the most abundant one. The cyanidin-3-O-glucoside accounted for 86% of all anthocyanins. Among flavonoids, the most represented ones were quercetin-HMG-glucoside and a kaempferol derivative, while ellagic acid glucuronide was the predominant ellagitannin. The extract showed significantly higher α-glucosidase inhibition with an IC50 value of 2.8 µg/mL, 32 times more effective than acarbose, and it markedly inhibited IAPP aggregation in a dose-dependent manner. It demonstrated antioxidant activity in cellular and acellular systems, without cytotoxicity. Caspase-1 activity was also reduced in intestinal cells. These findings support R. ulmifolius fruits as a promising functional food for managing T2D and preserving pancreatic function.

## Linked entities

- **Proteins:** Caspase1 (caspase-1)
- **Chemicals:** acarbose (PubChem CID 9811704), cyanidin-3-O-glucoside (PubChem CID 197081), kaempferol (PubChem CID 5280863)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** IAPP (islet amyloid polypeptide) [NCBI Gene 3375] {aka DAP, IAP}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, SI (sucrase-isomaltase) [NCBI Gene 6476]
- **Diseases:** inflammatory (MESH:D007249), cytotoxicity (MESH:D064420), T2D (MESH:D003924)
- **Chemicals:** anthocyanin (MESH:D000872), carbohydrate (MESH:D002241), flavonoids (MESH:D005419), cyanidin-3-O-glucoside (MESH:C462279), kaempferol (MESH:C006552), acarbose (MESH:D020909), R. ulmifolius fruits (-), ellagitannin (MESH:C013515)
- **Species:** Rubus ulmifolius (species) [taxon 75099]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608329/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608329/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608329/full.md

---
Source: https://tomesphere.com/paper/PMC12608329